Risultati della ricerca - W. Fraser Symmans

Raffina i risultati
  1. 1
    Breast cancer heterogeneity: Evaluation of clonality in primary and metastatic lesions

    Breast cancer heterogeneity: Evaluation of clonality in primary and metastatic lesions di W. Fraser Symmans, Jiguan Liu, Daniel M. Knowles, Giorgio Inghirami

    Pubblicazione 1995
    Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  2. 2
    Fine-needle aspiration cytology of Hodgkin disease

    Fine-needle aspiration cytology of Hodgkin disease di David C. Chhieng, Joan Cangiarella, W. Fraser Symmans, Jean‐Marc Cohen

    Pubblicazione 2001
    Testo Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  3. 3
    Optimal fixation conditions for immunocytochemical analysis of estrogen receptor in cytologic specimens of breast carcinoma

    Optimal fixation conditions for immunocytochemical analysis of estrogen receptor in cytologic specimens of breast carcinoma di Yun Gong, W. Fraser Symmans, Savitri Krishnamurthy, Shobha Patel, Nour Sneige

    Pubblicazione 2003
    Testo Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  4. 4
    Molecular Classification of Breast Cancer: Limitations and Potential

    Molecular Classification of Breast Cancer: Limitations and Potential di Lajos Pusztai, Chafika Mazouni, K. Anderson, Yun Wu, W. Fraser Symmans

    Pubblicazione 2006
    Testo Testo
    Revisão
    Aggiungi alla lista
    Salvato in:
  5. 5
    The Bimodality Index: A criterion for Discovering and Ranking Bimodal Signatures from Cancer Gene Expression Profiling Data

    The Bimodality Index: A criterion for Discovering and Ranking Bimodal Signatures from Cancer Gene Expression Profiling Data di Jing Wang, Sijin Wen, W. Fraser Symmans, Lajos Pusztai, Kevin R. Coombes

    Pubblicazione 2009
    Testo Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  6. 6
    Commercialized Multigene Predictors of Clinical Outcome for Breast Cancer

    Commercialized Multigene Predictors of Clinical Outcome for Breast Cancer di Jeffrey S. Ross, Christos Hatzis, W. Fraser Symmans, Lajos Pusztai, Gabriel N. Hortobágyi

    Pubblicazione 2008
    Testo Testo
    Revisão
    Aggiungi alla lista
    Salvato in:
  7. 7
    Accurate RNA Sequencing From Formalin-Fixed Cancer Tissue to Represent High-Quality Transcriptome From Frozen Tissue

    Accurate RNA Sequencing From Formalin-Fixed Cancer Tissue to Represent High-Quality Transcriptome From Frozen Tissue di Jialu Li, Chunxiao Fu, Terence P. Speed, Wenyi Wang, W. Fraser Symmans

    Pubblicazione 2018
    Testo Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  8. 8
    Centromere protein-A, an essential centromere protein, is a prognostic marker for relapse in estrogen receptor-positive breast cancer

    Centromere protein-A, an essential centromere protein, is a prognostic marker for relapse in estrogen receptor-positive breast cancer di Susan L. McGovern, Yuan Qi, Lajos Pusztai, W. Fraser Symmans, Thomas A. Buchholz

    Pubblicazione 2012
    Testo Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  9. 9
    The HER-2 Receptor and Breast Cancer: Ten Years of Targeted Anti–HER-2 Therapy and Personalized Medicine

    The HER-2 Receptor and Breast Cancer: Ten Years of Targeted Anti–HER-2 Therapy and Personalized Medicine di Jeffrey S. Ross, Elzbieta Slodkowska, W. Fraser Symmans, Lajos Pusztai, Peter M. Ravdin, Gabriel N. Hortobágyi

    Pubblicazione 2009
    Testo Testo
    Revisão
    Aggiungi alla lista
    Salvato in:
  10. 10
    Mammotome core biopsy for mammary microcalcification

    Mammotome core biopsy for mammary microcalcification di Joan Cangiarella, Jerry Waisman, W. Fraser Symmans, Joshua Gross, Jean‐Marc Cohen, Horace Wu, Deborah Axelrod

    Pubblicazione 2001
    Testo Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  11. 11
    Reproducibility of residual cancer burden for prognostic assessment of breast cancer after neoadjuvant chemotherapy

    Reproducibility of residual cancer burden for prognostic assessment of breast cancer after neoadjuvant chemotherapy di Florentia Peintinger, Bruno V. Sinn, Christos Hatzis, Constance T. Albarracin, Erinn Downs‐Kelly, Jerzy Morkowski, Rebekah Gould, W. Fraser Symmans

    Pubblicazione 2015
    Testo Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  12. 12
    Evaluation of biological pathways involved in chemotherapy response in breast cancer

    Evaluation of biological pathways involved in chemotherapy response in breast cancer di Attila Tordai, Jing Wang, Fabrice André, Cornelia Liedtke, Kai Yan, Christos Sotiriou, Gabriel N. Hortobágyi, W. Fraser Symmans, Lajos Pusztai

    Pubblicazione 2008
    Testo Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  13. 13
    Effects of Tissue Handling on RNA Integrity and Microarray Measurements From Resected Breast Cancers

    Effects of Tissue Handling on RNA Integrity and Microarray Measurements From Resected Breast Cancers di Christos Hatzis, Hongxia Sun, Hui Yao, R Hubbard, Funda Meric‐Bernstam, Gildy V. Babiera, Yun Wu, Lajos Pusztai, W. Fraser Symmans

    Pubblicazione 2011
    Testo Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  14. 14
    Targeted Therapy in Breast Cancer

    Targeted Therapy in Breast Cancer di Jeffrey S. Ross, Jonathan A. Fletcher, Kenneth J. Bloom, Gerald P. Linette, James Stec, W. Fraser Symmans, Lajos Pusztai, Gabriel N. Hortobágyi

    Pubblicazione 2004
    Testo Testo
    Revisão
    Aggiungi alla lista
    Salvato in:
  15. 15
    Prospective Comparison of Clinical and Genomic Multivariate Predictors of Response to Neoadjuvant Chemotherapy in Breast Cancer

    Prospective Comparison of Clinical and Genomic Multivariate Predictors of Response to Neoadjuvant Chemotherapy in Breast Cancer di Jae K. Lee, Charles Coutant, Young Chul Kim, Yuan Qi, Dan Theodorescu, W. Fraser Symmans, Keith Baggerly, Roman Rouzier, Lajos Pusztai

    Pubblicazione 2010
    Testo Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  16. 16
    Microtubule-Associated Protein-tau is a Bifunctional Predictor of Endocrine Sensitivity and Chemotherapy Resistance in Estrogen Receptor–Positive Breast Cancer

    Microtubule-Associated Protein-tau is a Bifunctional Predictor of Endocrine Sensitivity and Chemotherapy Resistance in Estrogen Receptor–Positive Breast Cancer di Fabrice André, Christos Hatzis, K. Anderson, Christos Sotiriou, Chafika Mazouni, Jaime Mejia, Bailiang Wang, Gabriel N. Hortobágyi, W. Fraser Symmans, Lajos Pusztai

    Pubblicazione 2007
    Testo Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  17. 17
    Seventeen-gene signature from enriched Her2/Neu mammary tumor-initiating cells predicts clinical outcome for human HER2 <sup>+</sup> :ERα <sup>−</sup> breast cancer

    Seventeen-gene signature from enriched Her2/Neu mammary tumor-initiating cells predicts clinical outcome for human HER2 <sup>+</sup> :ERα <sup>−</sup> breast cancer di Jeff C. Liu, Véronique Voisin, Gary D. Bader, Tao Deng, Lajos Pusztai, W. Fraser Symmans, Francisco J. Esteva, Sean E. Egan, Eldad Zacksenhaus

    Pubblicazione 2012
    Testo Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  18. 18
    The impact of RNA extraction method on accurate RNA sequencing from formalin-fixed paraffin-embedded tissues

    The impact of RNA extraction method on accurate RNA sequencing from formalin-fixed paraffin-embedded tissues di Michał Marczyk, Chunxiao Fu, Rosanna Lau, Lili Du, Alexander J. Trevarton, Bruno V. Sinn, Rebekah Gould, Lajos Pusztai, Christos Hatzis, W. Fraser Symmans

    Pubblicazione 2019
    Testo Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  19. 19
    Tumor Biology and Response to Chemotherapy Impact Breast Cancer-specific Survival in Node-positive Breast Cancer Patients Treated With Neoadjuvant Chemotherapy

    Tumor Biology and Response to Chemotherapy Impact Breast Cancer-specific Survival in Node-positive Breast Cancer Patients Treated With Neoadjuvant Chemotherapy di Judy C. Boughey, Karla V. Ballman, Linda McCall, Elizabeth A. Mittendorf, W. Fraser Symmans, Thomas B. Julian, David R. Byrd, Kelly K. Hunt

    Pubblicazione 2017
    Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  20. 20
    Residual Ductal Carcinoma In Situ in Patients With Complete Eradication of Invasive Breast Cancer After Neoadjuvant Chemotherapy Does Not Adversely Affect Patient Outcome

    Residual Ductal Carcinoma In Situ in Patients With Complete Eradication of Invasive Breast Cancer After Neoadjuvant Chemotherapy Does Not Adversely Affect Patient Outcome di Chafika Mazouni, Florentia Peintinger, Shu Wan-Kau, Fabrice André, Ana M. González-Angulo, W. Fraser Symmans, Funda Meric‐Bernstam, Vicente Valero, Gabriel N. Hortobágyi, Lajos Pusztai

    Pubblicazione 2007
    Testo Testo
    Artigo
    Aggiungi alla lista
    Salvato in:

Strumenti per la ricerca: